A strategy to assess the cellular activity of E3 ligase components against neo-substrates using electrophilic probes

Selective inhibition of BET bromodomains

Filippakopoulos, P., Qi, J., Picaud, S., Shen, Y., Smith, W. B., Fedorov, O., Morse, E. M., Keates, T., Hickman, T. T., Felletar, I., et al. (2010) · Nature · doi:10.1038/nature09504 · Cited by 4,262 · see citing works

Phthalimide conjugation as a strategy for in vivo target protein degradation

Winter, G. E., Buckley, D. L., Paulk, J., Roberts, J. M., Souza, A., Dhe-Paganon, S., & Bradner, J. E. (2015) · Science · doi:10.1126/science.aab1433 · Cited by 1,760 · see citing works

Catalytic in vivo protein knockdown by small-molecule PROTACs

Bondeson, D. P., Mares, A., Smith, I. E. D., Ko, E., Campos, S., Miah, A. H., Mulholland, K. E., Routly, N., Buckley, D. L., Gustafson, J. L., et al. (2015) · Nature Chemical Biology · doi:10.1038/nchembio.1858 · Cited by 1,356 · see citing works

Structural basis of PROTAC cooperative recognition for selective protein degradation

Gadd, M. S., Testa, A., Lucas, X., Chan, K.-H., Chen, W., Lamont, D. J., Zengerle, M., & Ciulli, A. (2017) · Nature Chemical Biology · doi:10.1038/nchembio.2329 · Cited by 1,242 · see citing works

Electroporation of cell membranes

Tsong, T. Y. (1991) · Biophysical Journal · doi:10.1016/s0006-3495(91)82054-9 · Cited by 1,096 · see citing works

Selective Small Molecule Induced Degradation of the BET Bromodomain Protein BRD4

Zengerle, M., Chan, K.-H., & Ciulli, A. (2015) · ACS Chemical Biology · doi:10.1021/acschembio.5b00216 · Cited by 1,056 · see citing works

Targeted protein degradation: expanding the toolbox

Schapira, M., Calabrese, M. F., Bullock, A. N., & Crews, C. M. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0047-y · Cited by 960 · see citing works

Electroporation and Electrofusion in Cell Biology

Neumann, E., Sowers, A. E., & Jordan, C. A. (1989) · Springer eBooks · doi:10.1007/978-1-4899-2528-2 · Cited by 947 · see citing works

Lessons in PROTAC Design from Selective Degradation with a Promiscuous Warhead

Bondeson, D. P., Smith, B. E., Burslem, G. M., Buhimschi, A. D., Hines, J., Jaime-Figueroa, S., Wang, J., Hamman, B. D., Ishchenko, A., & Crews, C. M. (2018) · Cell Chemical Biology · doi:10.1016/j.chembiol.2017.09.010 · Cited by 923 · see citing works

The target landscape of clinical kinase drugs

Klaeger, S., Heinzlmeir, S., Wilhelm, M., Polzer, H., Vick, B., Koenig, P.-A., Reinecke, M., Ruprecht, B., Petzoldt, S., Meng, C., et al. (2017) · Science · doi:10.1126/science.aan4368 · Cited by 854 · see citing works

Structural basis for the recognition of hydroxyproline in HIF-1α by pVHL

Hon, W.-C., Wilson, M. I., Harlos, K., Claridge, T. D. W., Schofield, C. J., Pugh, C. W., Maxwell, P. H., Ratcliffe, P. J., Stuart, D. I., & Jones, E. Y. (2002) · Nature · doi:10.1038/nature00767 · Cited by 751 · see citing works

Tumour suppression by the human von Hippel-Lindau gene product

Iliopoulos, O., Kibel, A. S., Gray, S. G., & Kaelin, W. G. (1995) · Nature Medicine · doi:10.1038/nm0895-822 · Cited by 696 · see citing works

Project DRIVE: a compendium of cancer dependencies and synthetic lethal relationships uncovered by large-scale, deep RNAi screening

McDonald, E. R., de Weck, A., Schlabach, M. R., Billy, E., Mavrakis, K. J., Hoffman, G. R., Belur, D., Castelletti, D., Frias, E., Gampa, K., et al. (2017) · Cell · doi:10.1016/j.cell.2017.07.005 · Cited by 658 · see citing works

Targeted intracellular protein degradation induced by a small molecule: En route to chemical proteomics

Schneekloth, A. R., Pucheault, M., Tae, H. S., & Crews, C. M. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.07.114 · Cited by 635 · see citing works

Modular PROTAC design for the degradation of oncogenic BCR-ABL

Lai, A. C., Toure, M., Hellerschmied, D., Salami, J., Jaime‐Figueroa, S., Ko, E., Hines, J., & Crews, C. M. (2016) · Angewandte Chemie International Edition · doi:10.1002/anie.201507634 · Cited by 618 · see citing works

Plasticity in binding confers selectivity in ligand-induced protein degradation

Nowak, R. P., DeAngelo, S. L., Buckley, D., He, Z., Donovan, K. A., An, J., Safaee, N., Jedrychowski, M. P., Ponthier, C. M., Ishoey, M., et al. (2018) · Nature Chemical Biology · doi:10.1038/s41589-018-0055-y · Cited by 615 · see citing works

Chemical Genetic Control of Protein Levels: Selective in Vivo Targeted Degradation

Schneekloth, J. S., Fonseca, F. N., Koldobskiy, M. A., Mandal, A., Deshaies, R. J., Sakamoto, K. M., & Crews, C. M. (2004) · Journal of the American Chemical Society · doi:10.1021/ja039025z · Cited by 502 · see citing works

Electrophilic PROTACs that degrade nuclear proteins by engaging DCAF16

Zhang, X., Crowley, V. M., Wucherpfennig, T. G., Dix, M. M., & Cravatt, B. F. (2019) · Nature Chemical Biology · doi:10.1038/s41589-019-0279-5 · Cited by 487 · see citing works

Targeted Degradation of Oncogenic KRAS ^G12C by VHL-Recruiting PROTACs

Bond, M. J., Chu, L., Nalawansha, D. A., Li, K., & Crews, C. M. (2020) · ACS Central Science · doi:10.1021/acscentsci.0c00411 · Cited by 450 · see citing works

The CDK inhibitor CR8 acts as a molecular glue degrader that depletes cyclin K

Słabicki, M., Kozicka, Z., Petzold, G., Li, Y.-D., Manojkumar, M., Bunker, R. D., Donovan, K. A., Sievers, Q. L., Koeppel, J., Suchyta, D., et al. (2020) · Nature · doi:10.1038/s41586-020-2374-x · Cited by 433 · see citing works

Harnessing the anti-cancer natural product nimbolide for targeted protein degradation

Spradlin, J. N., Hu, X., Ward, C. C., Brittain, S. M., Jones, M. D., Ou, L., To, M., Proudfoot, A., Ornelas, E., Woldegiorgis, M., et al. (2019) · Nature Chemical Biology · doi:10.1038/s41589-019-0304-8 · Cited by 432 · see citing works

Protein Knockdown Using Methyl Bestatin−Ligand Hybrid Molecules: Design and Synthesis of Inducers of Ubiquitination-Mediated Degradation of Cellular Retinoic Acid-Binding Proteins

Itoh, Y., Ishikawa, M., Naito, M., & Hashimoto, Y. (2010) · Journal of the American Chemical Society · doi:10.1021/ja100691p · Cited by 404 · see citing works

Rational discovery of molecular glue degraders via scalable chemical profiling

Mayor-Ruiz, C., Bauer, S., Brand, M., Kozicka, Z., Siklos, M., Imrichova, H., Kaltheuner, I. H., Hahn, E., Seiler, K., Koren, A., et al. (2020) · Nature Chemical Biology · doi:10.1038/s41589-020-0594-x · Cited by 369 · see citing works

Covalent Ligand Screening Uncovers a RNF4 E3 Ligase Recruiter for Targeted Protein Degradation Applications

Ward, C. C., Kleinman, J. I., Brittain, S. M., Lee, P. S., Chung, C. Y. S., Kim, K., Petri, Y., Thomas, J. R., Tallarico, J. A., McKenna, J. M., et al. (2019) · ACS Chemical Biology · doi:10.1021/acschembio.8b01083 · Cited by 336 · see citing works

Degradation of the BAF Complex Factor BRD9 by Heterobifunctional Ligands

Remillard, D., Buckley, D. L., Paulk, J., Brien, G. L., Sonnett, M., Seo, H., Dastjerdi, S., Wühr, M., Dhe‐Paganon, S., Armstrong, S. A., et al. (2017) · Angewandte Chemie International Edition · doi:10.1002/anie.201611281 · Cited by 294 · see citing works

Development of dual and selective degraders of cyclin-dependent kinases 4 and 6

Jiang, B., Wang, E. S., Donovan, K. A., Liang, Y., Fischer, E. S., Zhang, T., & Gray, N. S. (2019) · Angewandte Chemie International Edition · doi:10.1002/anie.201901336 · Cited by 272 · see citing works

pVHL 19 is a biologically active product of the von Hippel–Lindau gene arising from internal translation initiation

Iliopoulos, O., Ohh, M., & Kaelin, W. G. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.20.11661 · Cited by 266 · see citing works

Structural basis of indisulam-mediated RBM39 recruitment to DCAF15 E3 ligase complex

Bussiere, D. E., Xie, L., Srinivas, H., Shu, W., Burke, A., Be, C., Zhao, J., Godbole, A., King, D., Karki, R. G., et al. (2020) · Nature Chemical Biology · doi:10.1038/s41589-019-0411-6 · Cited by 257 · see citing works

Targeting Cullin–RING E3 ubiquitin ligases for drug discovery: structure, assembly and small-molecule modulation

Bulatov, E., & Ciulli, A. (2015) · Biochemical Journal · doi:10.1042/bj20141450 · Cited by 237 · see citing works

Functional TRIM24 degrader via conjugation of ineffectual bromodomain and VHL ligands

Gechijian, L. N., Buckley, D. L., Lawlor, M. A., Reyes, J. M., Paulk, J., Ott, C. J., Winter, G. E., Erb, M. A., Scott, T. G., Xu, M., et al. (2018) · Nature Chemical Biology · doi:10.1038/s41589-018-0010-y · Cited by 222 · see citing works

Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma

Brien, G. L., Remillard, D., Shi, J., Hemming, M. L., Chabon, J., Wynne, K. J., Dillon, E., Cagney, G., van Mierlo, G., Baltissen, M. P. A., et al. (2018) · eLife · doi:10.7554/elife.41305 · Cited by 217 · see citing works

Discovery of a molecular glue promoting CDK12-DDB1 interaction to trigger cyclin K degradation

Lv, L., Chen, P., Cao, L., Li, Y., Zeng, Z., Cui, Y., Wu, Q., Li, J., Wang, J.-H., Dong, M.-Q., et al. (2020) · eLife · doi:10.7554/elife.59994 · Cited by 215 · see citing works

DCAF11 Supports Targeted Protein Degradation by Electrophilic Proteolysis-Targeting Chimeras

Zhang, X., Luukkonen, L. M., Eissler, C. L., Crowley, V. M., Yamashita, Y., Schafroth, M. A., Kikuchi, S., Weinstein, D. S., Symons, K. T., Nordin, B. E., et al. (2021) · Journal of the American Chemical Society · doi:10.1021/jacs.1c00990 · Cited by 199 · see citing works

Assessing Different E3 Ligases for Small Molecule Induced Protein Ubiquitination and Degradation

Ottis, P., Toure, M., Cromm, P. M., Ko, E., Gustafson, J. L., & Crews, C. M. (2017) · ACS Chemical Biology · doi:10.1021/acschembio.7b00485 · Cited by 176 · see citing works

Acute and rapid degradation of endogenous proteins by Trim-Away

Clift, D., So, C., McEwan, W. A., James, L. C., & Schuh, M. (2018) · Nature Protocols · doi:10.1038/s41596-018-0028-3 · Cited by 176 · see citing works

Peptide Level Turnover Measurements Enable the Study of Proteoform Dynamics

Zecha, J., Meng, C., Zolg, D. P., Samaras, P., Wilhelm, M., & Küster, B. (2018) · Molecular & Cellular Proteomics · doi:10.1074/mcp.ra118.000583 · Cited by 123 · see citing works

A Nimbolide-Based Kinase Degrader Preferentially Degrades Oncogenic BCR-ABL

Tong, B., Spradlin, J. N., Novaes, L. F. T., Zhang, E., Hu, X., Moeller, M., Brittain, S. M., McGregor, L. M., McKenna, J. M., Tallarico, J. A., et al. (2020) · ACS Chemical Biology · doi:10.1021/acschembio.0c00348 · Cited by 118 · see citing works

Development and Characterization of a Wee1 Kinase Degrader

Li, Z., Pinch, B. J., Olson, C. M., Donovan, K. A., Nowak, R. P., Mills, C. E., Scott, D. A., Doctor, Z. M., Eleuteri, N. A., Chung, M., et al. (2019) · Cell chemical biology · doi:10.1016/j.chembiol.2019.10.013 · Cited by 107 · see citing works

The SPRY domain–containing SOCS box protein SPSB2 targets iNOS for proteasomal degradation

Kuang, Z., Lewis, R. S., Curtis, J., Zhan, Y., Saunders, B. M., Babon, J. J., Kolesnik, T. B., Low, A., Masters, S. L., Willson, T. A., et al. (2010) · The Journal of Cell Biology · doi:10.1083/jcb.200912087 · Cited by 101 · see citing works

Targeting BCL-2 and ABL/LYN in Philadelphia chromosome–positive acute lymphoblastic leukemia

Leonard, J. T., Rowley, J., Eide, C. A., Traer, E. A., Hayes‐Lattin, B., Loriaux, M., Spurgeon, S. E. F., Druker, B. J., Tyner, J. W., & Chang, B. H. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aaf5309 · Cited by 81 · see citing works

Electroporated recombinant proteins as tools for in vivo functional complementation, imaging and chemical biology

Alex, A., Piano, V., Polley, S., Stuiver, M., Voß, S., Ciossani, G., Overlack, K., Voß, B., Wohlgemuth, S., Petrović, A., et al. (2019) · eLife · doi:10.7554/elife.48287 · Cited by 63 · see citing works

Electroporation of Cell Membranes

Tsong, T. Y. (1989) · Springer eBooks · doi:10.1007/978-1-4899-2528-2_9 · Cited by 56 · see citing works

The Mechanism of Ubiquitination in the Cullin-RING E3 Ligase Machinery: Conformational Control of Substrate Orientation

Liu, J., & Nussinov, R. (2009) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1000527 · Cited by 55 · see citing works

Identification of molecular targets for the targeted treatment of gastric cancer using dasatinib

Montenegro, R. C., Howarth, A., Ceroni, A., Fedele, V., Farran, B., Mesquita, F. P., Frejno, M., Berger, B., Heinzlmeir, S., Sailem, H., et al. (2020) · Oncotarget · doi:10.18632/oncotarget.27462 · Cited by 42 · see citing works

Developing Small‐Molecule Inhibitors of HECT‐Type Ubiquitin Ligases for Therapeutic Applications: Challenges and Opportunities

Chen, D., Gehringer, M., & Lorenz, S. (2018) · ChemBioChem · doi:10.1002/cbic.201800321 · Cited by 40 · see citing works

Application of CRISPR genetic screens to investigate neurological diseases

So, R. W. L., Chung, S., Lau, H. H. C., Watts, J. J., Gaudette, E. V., Al‐Azzawi, Z. A. M., Bishay, J., Lin, L. T., Joung, J., Wang, X., et al. (2019) · Molecular Neurodegeneration · doi:10.1186/s13024-019-0343-3 · Cited by 36 · see citing works

BC-box protein domain-related mechanism for VHL protein degradation

Pozzebon, M. E., Varadaraj, A., Mattoscio, D., Jaffray, E., Miccolo, C., Galimberti, V. E., Tommasino, M., Hay, R. T., & Chiocca, S. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1311382110 · Cited by 34 · see citing works

Discovery of novel 2-(aminoheteroaryl)-thiazole-5-carboxamides as potent and orally active Src-family kinase p56Lck inhibitors

Chen, P., Norris, D. J., Das, J., Spergel, S. H., Wityak, J., Leith, L. W., Zhao, R., Chen, B., Pitt, S., Pang, S., et al. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2004.09.093 · Cited by 33 · see citing works

Evolution of metazoan oxygen-sensing involved a conserved divergence of VHL affinity for HIF1α and HIF2α

Tarade, D., Lee, J. E., & Ohh, M. (2019) · Nature Communications · doi:10.1038/s41467-019-11149-1 · Cited by 21 · see citing works

Efficient electroporation of peptides into adherent cells: investigation of the role of mechano-growth factor in chondrocyte culture

Schönenberger, C., Schütz, A., Franco‐Obregón, A., & Zenobi‐Wong, M. (2011) · Biotechnology Letters · doi:10.1007/s10529-010-0508-1 · Cited by 19 · see citing works

Crystal structure of SPSB2 in complex with a rational designed RGD-containing cyclic peptide inhibitor of SPSB2-iNOS interaction

You, T., Wang, Y., Li, K., Zhang, D., Wei, H., Luo, Y., Li, H., Lu, Y., Su, X., & Kuang, Z. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.05.122 · Cited by 19 · see citing works

Publisher Correction: Two dynamically distinct circuits drive inhibition in the sensory thalamus

Martinez-Garcia, R. I., Voelcker, B., Zaltsman, J. B., Patrick, S. L., Stevens, T. R., Connors, B. W., & Cruikshank, S. J. (2020) · Nature · doi:10.1038/s41586-020-2680-3 · Cited by 4 · see citing works

Chasing molecular glue degraders: screening approaches

Domostegui, A., Nieto-Barrado, L., Perez-Lopez, C., & Mayor-Ruiz, C. (2022) · Chemical Society Reviews · doi:10.1039/d2cs00197g · Cited by 200 · see citing works

From Conception to Development: Investigating PROTACs Features for Improved Cell Permeability and Successful Protein Degradation

Cecchini, C., Pannilunghi, S., Tardy, S., & Scapozza, L. (2021) · Frontiers in Chemistry · doi:10.3389/fchem.2021.672267 · Cited by 198 · see citing works

E3 ligase ligand chemistries: from building blocks to protein degraders

Sosič, I., Bricelj, A., & Steinebach, C. (2022) · Chemical Society Reviews · doi:10.1039/d2cs00148a · Cited by 173 · see citing works

DCAF1-based PROTACs with activity against clinically validated targets overcoming intrinsic- and acquired-degrader resistance

Schröder, M., Renatus, M., Liang, X., Meili, F., Zoller, T., Ferrand, S., Gauter, F., Li, X., Sigoillot, F. D., Gleim, S., et al. (2024) · Nature Communications · doi:10.1038/s41467-023-44237-4 · Cited by 108 · see citing works

Expanding the landscape of E3 ligases for targeted protein degradation

Kramer, L. T. S., & Zhang, X. (2022) · Current Research in Chemical Biology · doi:10.1016/j.crchbi.2022.100020 · Cited by 69 · see citing works

Revolutionizing Drug Targeting Strategies: Integrating Artificial Intelligence and Structure-Based Methods in PROTAC Development

Danishuddin, M., Jamal, M. S., Song, K. S., Lee, K., Kim, J.-J., & Park, Y. (2023) · Pharmaceuticals · doi:10.3390/ph16121649 · Cited by 50 · see citing works

PROTACs, molecular glues and bifunctionals from bench to bedside: Unlocking the clinical potential of catalytic drugs

Maneiro, M., Vita, E. D., Conole, D., Kounde, C. S., Zhang, Q., & Tate, E. W. (2021) · Progress in medicinal chemistry · doi:10.1016/bs.pmch.2021.01.002 · Cited by 38 · see citing works

Drug Discovery Approaches to Target E3 Ligases

Rodríguez-Gimeno, A., & Galdeano, C. (2024) · ChemBioChem · doi:10.1002/cbic.202400656 · Cited by 37 · see citing works

Identification of Actionable Targeted Protein Degradation Effector Sites through Site-Specific Ligand Incorporation-Induced Proximity (SLIP)

Xiao, Z., Gavriil, E.-S., Cao, F., Zhang, X., Li, S. X., Kotelnikov, S., Michalska, P., Marte, F., Huang, C., Lu, Y., et al. (2025) · Journal of the American Chemical Society · doi:10.1021/jacs.5c01420 · Cited by 17 · see citing works

The ubiquitin E3 ligase BFAR promotes degradation of PNPLA3

Das, A., Cheng, H., Wang, Y., Kinch, L. N., Liang, G., Hong, S., Hobbs, H. H., & Cohen, J. C. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2312291121 · Cited by 17 · see citing works

In-Cell Approach to Evaluate E3 Ligases for Use in Targeted Protein Degradation

Zheng, Y., Singh, A., Niu, Z., Marin, V. L., Young, J., Richardson, P. L., Hemshorn, M. L., Cooley, R. B., Karplus, P. A., Puvar, K., et al. (2025) · Journal of the American Chemical Society · doi:10.1021/jacs.5c02741 · Cited by 15 · see citing works

Investigating protein degradability through site-specific ubiquitin ligase recruitment

Shade, O., Ryan, A., Belsito, G., & Deiters, A. (2024) · RSC Chemical Biology · doi:10.1039/d4cb00273c · Cited by 9 · see citing works

Structural basis for DCAF2 as a novel E3 ligase for PROTAC-mediated targeted protein degradation

McMahon, E., Cioffi, A. G., Visperas, P. R., Lin, Y., Shaghafi, M. B., Daczkowski, C. M., Hermann, J. C., Everley, R. A., Neve, R. M., Erlanson, D. A., et al. (2025) · Structure · doi:10.1016/j.str.2025.09.006 · Cited by 11 · see citing works

Reinstating targeted protein degradation with DCAF1 PROTACs in CRBN PROTAC resistant settingsPreprint

Schröder, M., Renatus, M., Liang, X., Meili, F., Zoller, T., Ferrand, S., Gauter, F., Li, X., Sigoillot, F. D., Gleim, S., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.04.09.536153 · Cited by 8 · see citing works

Small molecule targeted protein degradation via the UPS: venturing beyond E3 substrate receptors

Guo, R., Yang, F., & Cherney, E. C. (2025) · RSC Medicinal Chemistry · doi:10.1039/d4md00718b · Cited by 6 · see citing works

Site-resolved assessment of targeted protein degradation

Moreno-Ballesteros, R., Pembridge, T., Beniwal, G., & Virdee, S. (2025) · Cell chemical biology · doi:10.1016/j.chembiol.2025.06.002 · Cited by 5 · see citing works

Discovery of a Series of Covalent Ligands That Bind to Cys77 of the Von Hippel–Lindau Tumor Suppressor Protein (VHL)

Lucas, S. C. C., Xu, Y., Hewitt, S. H., Collie, G. W., Fusani, L., Kadamur, G., Hadfield, T. E., Su, N., Truman, C., Demanze, S., et al. (2025) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.4c00582 · Cited by 3 · see citing works

Insights and Future Perspectives of Covalent Protein Degraders

Zhang, X. (2022) · Wiley eBooks · doi:10.1002/9783527836208.ch8 · Cited by 2 · see citing works

New Therapeutic Chemical Modalities: Compositions, Modes-of-action, and Drug Discovery

Valeur, E. (2023) · Royal Society of Chemistry eBooks · doi:10.1039/9781788018982-00911

His-Tag-Binding DNA Aptamer–JQ1 Conjugates Enable Comparative In Vitro Profiling of BRD4 UbiquitinationPreprint

Okitsu, K., Tsuji, G., & Demizu, Y. (2026) · SSRN Electronic Journal · doi:10.2139/ssrn.7576374

Abstract 6411: Discovery of covalent ligands to novel E3 ligases enables bispecific degraders with highly differentiated protein degradation across a broad range of targets

Baltgalvis, K. A., Kikuchi, S., Symons, K. T., Klebba, J. E., Luukkonen, L., Naro, Y., Walsh, C. T., Chang, J., Chapman, C., Tabatabaei, A., et al. (2020) · Cancer Research · doi:10.1158/1538-7445.am2020-6411 · Cited by 1 · see citing works

In-Cell Approach to Evaluate E3 Ligases for Use in Targeted Protein Degradation

Zheng, Y., Singh, A., Niu, Z., Marin, V. L., Young, J., Richardson, P. L., Hemshorn, M. L., Cooley, R. B., Karplus, P. A., Puvar, K., et al. (2025) · Journal of the American Chemical Society · doi:10.1021/jacs.5c02741 · Cited by 15 · see citing works

A critical evaluation of the approaches to targeted protein degradation for drug discovery

Chopra, R., Sadok, A., & Collins, I. (2019) · Drug Discovery Today: Technologies · doi:10.1016/j.ddtec.2019.02.002 · Cited by 53 · see citing works

Covalent Ligand Screening Uncovers a RNF4 E3 Ligase Recruiter for Targeted Protein Degradation Applications

Ward, C. C., Kleinman, J. I., Brittain, S. M., Lee, P. S., Chung, C. Y. S., Kim, K., Petri, Y., Thomas, J. R., Tallarico, J. A., McKenna, J. M., et al. (2019) · ACS Chemical Biology · doi:10.1021/acschembio.8b01083 · Cited by 336 · see citing works

Implications of frequent hitter E3 ligases in targeted protein degradation screens

Zhang, X., Simon, G. M., & Cravatt, B. F. (2025) · Nature Chemical Biology · doi:10.1038/s41589-024-01821-z · Cited by 33 · see citing works